Lung Cancers Unknown Status Phase 2 Trials for Erlotinib (DB00530)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00801385Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to ChemotherapyTreatment
NCT00620269Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC IIITreatment
NCT00550537Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerTreatment
NCT00278187Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment